Skip to content

Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache

Study of Effects of Metoclopramide Versus Sumatriptan on Migraine Headache

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01791400
Enrollment
124
Registered
2013-02-15
Start date
2009-07-31
Completion date
2010-11-30
Last updated
2013-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Disorders

Keywords

Metoclopramide, Sumatriptan, migraine, headache

Brief summary

The purpose of this study is to determine which drug makes lower migraine headache

Detailed description

There are different options to manage benign headache in emergency department.The investigators compared Intravenous metoclopramide with Subcutaneous sumatriptan to relieve pain in emergency department.

Interventions

DRUGmetoclopramide, injection,20mg, one time

metoclopramide, intravenous injection,20mg, one time

DRUGSumatriptan, injection, 6 mg, one time

Sumatriptan, subcutaneous injection, 6 mg, one time

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* 20-60 years old and presented with acute headache similar to previous episodes, * with or without phonophobia, * photophobia, * vomiting or nausea.

Exclusion criteria

* fever or neck stiffness, * altered mental state, * pregnancy, * recent trauma or seizure (within 24 hours), * focal neurological abnormality on physical examination, * allergy to metoclopramide, * hypertension, * cardiovascular diseases. Also if the patients had taken a triptan or ergot during the last 24 hours were excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
painat one hour after prescriptiondetermining pain in Metoclopramide versus sumatriptan groups

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026